Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000455914 | SCV000538696 | benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF |
Mendelics | RCV000004721 | SCV001138646 | benign | Familial chronic mucocutaneous candidiasis | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002504746 | SCV002804575 | likely benign | Familial chronic mucocutaneous candidiasis; Aspergillosis, susceptibility to | 2022-04-21 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004706445 | SCV005233553 | benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000004721 | SCV000024896 | pathogenic | Familial chronic mucocutaneous candidiasis | 2010-12-09 | no assertion criteria provided | literature only | |
OMIM | RCV000023528 | SCV000044819 | risk factor | Aspergillosis, susceptibility to | 2010-12-09 | no assertion criteria provided | literature only | |
Prevention |
RCV003974796 | SCV004790226 | likely benign | CLEC7A-related disorder | 2022-05-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |